Catalyst Wire Dossier Catalyst Wire Dossier

EMEND

aprepitant · Merck & Co.
Drug timelines are a Plus or Pro feature.

64 regulatory and trial events tracked for EMEND, covering 2006-06-09 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients [Phase 3]

See pricing